Hope Pharmaceuticals develops global patent portfolio relating to highly purified forms of sodium nitrite and sodium thiosulfate
Client(s) Hope Pharmaceuticals
Jones Day represents Hope Pharmaceuticals in the establishment of a global patent portfolio related to highly purified forms of sodium nitrite and sodium thiosulfate relating to its FDA-approved cyanide antidote NITHIODOTE®.